JASPER™ Robotic Surgical System (Formerly Known as the ORYOM™ Robotic Surgical System) in Cataract Surgery

Single-site, Open-label, Prospective Feasibility Study Performed Using the JASPER™ Robotic Surgical System in Cataract Surgery Procedures

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07468409

Enrollment

Registered

2026-03-12

Start date

2026-02-20

Completion date

2027-04-01

Last updated

2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

This is a prospective, open-label clinical study designed to evaluate the performance and safety of the JASPER™ Robotic Surgical System during cataract surgery.

Interventions

DEVICEJASPER™ Robotic Surgical System

The JASPER™ Robotic Surgical System is a robotically assisted surgical system intended to assist ophthalmic surgeons in performing cataract surgery.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

55 Years to 80 Years

Healthy volunteers

Inclusion criteria

Main Inclusion Criteria: * Patient aged 55 to 80 years * Willing and able to sign an informed consent, attend the clinic and comply with all study procedures and the study protocol * Patients are scheduled to undergo cataract surgery * Clear intraocular media, other than cataract * Pupil dilate according to stand of care Main

Exclusion criteria

* Prior ocular surgery or trauma in the study eye * Polar cataract in the study eye * Zonular instability or significant anterior segment abnormalities * Active ocular infection or uveitis * Pseudoexfoliation (PXF) syndrome in either eye * ASA Physical Status Classification \> 3 * Participation in another clinical trial within 30 days

Design outcomes

Primary

Measure	Time frame	Description
Successful completion of planned Robotic-Assisted cataract surgery	Intra-operative	Proportion of study eyes in which the planned robotic cataract surgery is completed using the JASPER™ Robotic Surgical System without conversion to manual technique.

Secondary

Measure	Time frame	Description
Incidence and Type of Adverse Events (AEs) and Serious Adverse Events (SAEs)	From surgery through 30 days post-procedure	Incidence and type of all AEs and SAEs occurring intraoperatively and during the postoperative follow-up period.
Distribution of pre and postoperative Best Corrected Visual acuity	Baseline and up to 30 days post-procedure	Distribution of preoperative and postoperative BCVA
Postoperative Ophthalmic examination findings	Up to 30 days post-procedure	Postoperative slit lamp and dilated fundus examinations findings

Countries

Philippines

Contacts

CONTACTMerav Gat, M.Sc., MBA

merav.gat@forsightrobotics.com+972547800259

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026